Stay updated on Pembrolizumab and Epacadostat in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Epacadostat in Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab and Epacadostat in Melanoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new revision tag v3.7.0 was added to the record history, indicating a newer version of the study record. The previous revision tag v3.6.6 was removed from the history.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe revision history now lists Revision: v3.6.6 as the current version. The prior Revision: v3.6.5 entry has been removed.SummaryDifference0.1%

- Check53 days agoChange DetectedA new revision label v3.6.5 appears in the version history, replacing the previous v3.6.4.SummaryDifference0.1%

- Check68 days agoChange DetectedThe study record history now shows a new revision entry (v3.6.4) replacing the previous (v3.6.3), indicating an update to the page's version history. This is a minor metadata update that tracks the latest revision of the record.SummaryDifference0.1%

- Check89 days agoChange DetectedThe study record history now includes a new Revision: v3.6.3 entry and removes the previous Revision: v3.6.2 entry. This updates the version history to reflect the latest release label.SummaryDifference0.1%

- Check96 days agoChange DetectedA new latest revision, v3.6.2, is added to the history and the previous v3.6.0 entry is removed, indicating a minor backend update to the page’s record-keeping.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab and Epacadostat in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Epacadostat in Melanoma Clinical Trial page.